Rapid vascular responses to anthrax lethal toxin in mice containing a segment of chromosome 11 from the CAST/Ei strain on a C57BL/6 genetic background.
Host allelic variation controls the response to B. anthracis and the disease course of anthrax. Mouse strains with macrophages that are responsive to anthrax lethal toxin (LT) show resistance to infection while mouse strains with LT non-responsive macrophages succumb more readily. B6.CAST.11M mice have a region of chromosome 11 from the CAST/Ei strain (a LT responsive strain) introgressed onto a LT non-responsive C57BL/6J genetic background. Previously, B6.CAST.11M mice were found to exhibit a rapid inflammatory reaction to LT termed the early response phenotype (ERP), and displayed greater resistance to B. anthracis infection compared to C57BL/6J mice. Several ERP features (e.g., bloat, hypothermia, labored breathing, dilated pinnae vessels) suggested vascular involvement. To test this, Evan's blue was used to assess vessel leakage and intravital microscopy was used to monitor microvascular blood flow. Increased vascular leakage was observed in lungs of B6.CAST.11M mice compared to C57BL/6J mice 1 hour after systemic administration of LT. Capillary blood flow was reduced in the small intestine mesentery without concomitant leukocyte emigration following systemic or topical application of LT, the latter suggesting a localized tissue mechanism in this response. Since LT activates the Nlrp1b inflammasome in B6.CAST.11M mice, the roles of inflammasome products, IL-1β and IL-18, were examined. Topical application to the mesentery of IL-1β but not IL-18 revealed pronounced slowing of blood flow in B6.CAST.11M mice that was not present in C57BL/6J mice. A neutralizing anti-IL-1β antibody suppressed the slowing of blood flow induced by LT, indicating a role for IL-1β in the response. Besides allelic differences controlling Nlrp1b inflammasome activation by LT observed previously, evidence presented here suggests that an additional genetic determinant(s) could regulate the vascular response to IL-1β. These results demonstrate that vessel leakage and alterations to blood flow are part of the rapid response in mice resistant to B. anthracis infection.
Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Kansas, United States of America.
Kelsey J
KJ
Weigel
Laura
L
Rues
Edward J
EJ
Doyle
Cassandra L
CL
Buchheit
John G
JG
Wood
Ryan J
RJ
Gallagher
Laura E
LE
Kelly
Jeffrey D
JD
Radel
Kenneth A
KA
Bradley
Steven M
SM
LeVine
D000818:Animals; D000881:Anthrax / Q000235:genetics / Q000276:immunology; D000942:Antigens, Bacterial / Q000008:administration & dosage / Q000276:immunology*; D001427:Bacterial Toxins / Q000008:administration & dosage / Q000276:immunology*; D001808:Blood Vessels / Q000187:drug effects / Q000276:immunology*; D002199:Capillary Permeability / Q000187:drug effects / Q000276:immunology; D033481:Chromosomes, Mammalian; D004195:Disease Models, Animal; D020022:Genetic Predisposition to Disease; D020382:Interleukin-18 / Q000008:administration & dosage / Q000276:immunology; D053583:Interleukin-1beta / Q000008:administration & dosage / Q000276:immunology; D008168:Lung / Q000276:immunology / Q000473:pathology; D008643:Mesentery / Q000098:blood supply; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D012039:Regional Blood Flow / Q000187:drug effects / Q000276:immunology
D000942:Antigens, Bacterial; D001427:Bacterial Toxins; D020382:Interleukin-18; D053583:Interleukin-1beta; C030325:anthrax toxin